Alidor Gaspar: When engagement feels like you're being used to share your experience only to be forgotten afterwards, it ...
The results of a phase 3 trial of Vertanical's cannabis-derived therapy VER-01 for chronic lower back pain have been ...
A new £1.2 billion science and technology park was formally opened today in Oxford, in a welcome boost to the UK's life ...
Cilento speaks to the advancement from GenAI to agentic AI, what’s changed for his own team in this regard and what’s ...
AbbVie suggested that it may not be able to launch its new ovarian cancer therapy Elahere (mirvetuximab soravtansine) for use ...
Novartis and Boehringer Ingelheim are the latest pharma groups to launch DTC platforms offering cut-price medicines to US ...
NHS England said that the launch of the service in 2027 will mean that patients will be seen faster, predicting that it will ...
In the past, it was easier for pharma to think of launch readiness as a checklist: secure NICE approval, mobilise commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback